Archive - January 2021
Valneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
The scent of sickness: 5 questions answered about using dogs – and mice and ferrets – to detect disease
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial
Sinovac’s COVID-19 vaccine demonstrates 50.4% efficacy in Brazilian trial data
Merck wins speedy FDA review for 15-valent pneumococcal vaccine
Hospitals’ Rocky Rollout of Covid Vaccine Sparks Questions of Fairness
Pfizer makes first investments through ‘breakthrough growth’ fund